ZappRx is a mobile platform company that has raised $1 million in seed funding led by Atlas Venture. This round of funding also includes SR One and GlaxoSmithKline. ZappRx previously received $1 million from Atlas Venture in September 2013.
This round of funding will be used for expanding the app. Pharmacies use the app to take allow patients to input and manage their medications on a smartphone. This expansion will go towards users that require specialty pharmaceuticals.
?In sharing the ZappRx solution with advisors, investors, and future customers, we learned that we had built a platform that reached far beyond the scope we?d originally envisioned for traditional retail,? stated Zoe Barry, founder and CEO of ZappRx. ?Due to the complex and custom challenges associated with ordering specialty medications, no automated system currently exists for patients who need it most.?
Specialty pharmaceuticals includes medicine for cancer and chronic illnesses such as HIV and and Crohn?s Disease.